Key points are not available for this paper at this time.
Background/Objectives: Breast cancer is the most prevalent neoplasm in women. Improved screening and systemic therapies have allowed more patients to choose breast-conserving surgery over mastectomy. However, preserving glandular tissue while achieving negative margins remains difficult. Traditional intraoperative margin assessment techniques like frozen section analysis, cavity shave margins, intraoperative ultrasonography, and specimen radiography aim to reduce positive margins and re-excision rates but face several limitations, including time consumption, interpretive challenges, and operator dependency. Our aim was to critically evaluate both conventional and emerging intraoperative margin assessment techniques in breast-conserving surgery, highlighting their clinical utility, limitations, and potential to reduce re-excision rates and improve patient outcomes. Methods: We assessed PubMed and Google Scholar databases using search terms such as specimen radiography, intraoperative ultrasonography, mass spectrometry, optical coherence tomography, artificial intelligence, and others. Studies were selected based on relevance, language, and completeness, and refined through author consensus. Conclusions: Conventional techniques have demonstrated value in reducing re-excisions and preserving cosmetic outcomes. Emerging tools like MarginProbe, fluorescence imaging, mass spectrometry (MasSpec Pen, iKnife), OCT, and AI-enhanced imaging show promise in offering real-time feedback and higher diagnostic accuracy. However, high costs, training needs, and data variability limit their widespread adoption. Investment in standardised protocols and multicentre trials is essential. Integration of imaging, spectroscopy, and AI may offer the most robust framework for improving surgical outcomes and quality of life for breast cancer patients.
Ivanov et al. (Wed,) studied this question.